Judging by the wording in the 8k/press release it seems that Redman addressed all the major concerns he was getting in emails. Like, no split of any kind...no Kistler is not involved, yes we are doing a reverse merger and it is happening in July. What more could you possibly want? Except of course, orphan drug in FDA trials. 8 US parents...worldwide patents, venture capitalist funding, funding from a former Glaxo executive...that sort of thing. This is gold, has been for months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.